Harnessing the Potential of Bacteriocin in the Treatment of Typhoid Fever and Cholera: A Systematic Review
Background: Typhoid fever kills 135,000 to 230,000 people every year and affects an estimated 11–21 million people globally. About 95,000 people die annually from cholera, and an additional 2.86 million get infected. Bacteriocins have been reported to inhibit the growth of various pathogens such as...
Saved in:
Main Authors: | Samson Baranzan Wayah, Atika Abubakar-Garba Faila, Peter Ojodale Adejo, Mariya Abubakar Balarabe, Zaharaddeen Abdullahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nigerian Medical Association, Akwa Ibom State Branch
2025-04-01
|
Series: | Ibom Medical Journal |
Subjects: | |
Online Access: | http://ibommedicaljournal.org/index.php/imjhome/article/view/660 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EPIDEMIOLOGICAL FEATURES AND EVOLUTION OF CLINICAL PRESENTATION OF TYPHOID FEVER IN SAINT-PETERSBURG
by: K. E. Novak, et al.
Published: (2019-03-01) -
Prevalence and antimicrobial susceptibility of Salmonella enterica Typhi in febrile patients: a cross-sectional study
by: Zainab Khattak, et al.
Published: (2025-06-01) -
Outbreak of Ceftriaxone-Resistant Salmonella enterica Serovar Typhi, Bangladesh, 2024
by: Yogesh Hooda, et al.
Published: (2025-07-01) -
Organization of Joint Laboratory Studies during Sanitary and Epidemiological Interventions in the Republic of the Congo by Rospotrebnadzor Specialists
by: S. A. Portenko, et al.
Published: (2024-07-01) -
Cholera Toxin Production and Localization in Vesicles of Vibrio cholerae El Tor Genovariants
by: L. P. Alekseeva, et al.
Published: (2024-07-01)